Drug capture materials based on genomic DNA-functionalized magnetic nanoparticles

Area of Science:

• Biomaterials Science
• Nanotechnology
• Oncology

Background:

• Chemotherapy agents cause severe side effects due to systemic distribution.
• Targeted drug delivery and sequestration are crucial for mitigating off-target damage.
• Effective materials for capturing chemotherapeutics in vivo are needed.

Purpose of the Study:

• To develop novel magnetic nanoparticles for capturing chemotherapy drugs.
• To evaluate the efficacy of DNA-coated nanoparticles in drug sequestration.
• To assess the potential of these materials for reducing chemotherapy-related toxicity.

Main Methods:

• Covalent attachment of genomic DNA to iron-oxide nanoparticles.
• Magnetic capture of chemotherapy agents (doxorubicin, cisplatin, epirubicin) from biological solutions.
• In vitro assessment of cardiac myoblast protection from doxorubicin.
• In vivo efficacy testing in a porcine model.

Main Results:

• Achieved 98% capture of doxorubicin from human serum within 10 minutes.
• DNA-coated particles successfully protected cultured cardiac myoblasts from lethal doxorubicin doses.
• Demonstrated in vivo efficacy of the DNA-coated nanoparticles in a porcine model.

Conclusions:

• Genomic DNA-coated iron-oxide nanoparticles are effective for capturing chemotherapy agents.
• These materials show significant potential for targeted drug delivery and reducing systemic toxicity.
• The developed nanoparticles represent a viable substrate for advanced drug capture applications in cancer therapy.